Drug details

Oxbryta (voxelotor tablets)

type of Hemoglobin Oxygen-Affinity Modulators

Oxbryta (voxelotor) is a hemoglobin S polymerization inhibitor used to treat sickle cell disease in adults and pediatric patients 12 years of age and older.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• itching
• rash, and
• severe dizziness,

The following drugs are related to Oxbryta, either as a replacement or used together:

• Adakveo (crizanlizumab-tmca injection)
• Droxia (hydroxyurea capsules)
• Endari (l-glutamine oral powder)
• Hydrea (hydroxyurea)
• Siklos (hydroxyurea tablets, for oral use)
• NutreStore (l-glutamine powder for oral solution)